Hodogaya Chemical Co., Ltd.

4112.T
Specialty Chemicals
2026/11/18 13:39 Updated
Market Cap: $192.7M (¥30.7B)
Stock Price: $12.10 (¥1,930)
Exchange Rate: 1 USD = ¥159.49

Fiscal 2026 Q2 Financial Summary (Consolidated)

Consolidated results for H1 FY2026: net sales 26,587 million yen, operating income 3,407 million yen, ordinary income 3,561 million yen, interim net income attributable to owners of parent 1,539 million yen. Year-on-year net sales increased by 4,041 million yen (+17.9%), and operating income rose sharply by 1,874 million yen (+122.3%). Full-year forecasts were revised to net sales 54,000 million yen, operating income 4,900 million yen, and an interim dividend of 30 yen per share, among others. The results reflect one-off items such as advisory fees related to the acquisition of Framochem and costs associated with SFC listing. Dividends are planned at 30 yen per share interim and 30 yen per share year-end, totaling 60 yen per share annually (policy aiming for DOE of 3%).

Importance:
Page Updated: November 11, 2026
IR Disclosure Date: November 11, 2026

Key Figures

  • Net Sales: 26,587 million yen
  • Operating Income: 3,407 million yen
  • Ordinary Income: 3,561 million yen
  • Interim Net Income Attributable to Owners of Parent: 1,539 million yen
  • Interim Net Income per Share: 96.71 yen

AI要約

Financial Summary

Consolidated results for Q2 FY2026: net sales increased by 4,041 million yen year-on-year (+17.9%) to 26,587 million yen. Increased sales of OLED materials in the Functional Dyes segment contributed, and operating income improved substantially to 3,407 million yen, up 1,874 million yen year-on-year (+122.3%). Ordinary income was 3,561 million yen, and interim net income attributable to owners of parent was 1,539 million yen. Key factors included one-off expenses such as advisory fees related to the acquisition of Framochem and foreign exchange effects.

Outlook and Dividends

Full-year forecasts for FY2026 have been revised to net sales of 54,000 million yen, operating income of approximately 4,900 million yen, and ordinary income around 4,500 million yen. An interim dividend of 30 yen per share and a year-end dividend of 30 yen per share are planned, with a shareholder return policy targeting a DOE of 3% or higher. Risks to monitor include prolonged Middle East tensions leading to higher raw material and fuel costs and economic uncertainty. The company will continue pursuing discontinuous growth strategies, including completing the acquisition of Framochem as a wholly owned subsidiary (completed in August).

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Hodogaya Chemical Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →